Precision BioScience
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
302 E Pettigrew St Ste A100, Durham, Nor...Phone Number
(919) 314-5512Website
www.precisionbiosciences.comRevenue
$34.3 MillionStock Symbol
DTILIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Precision BioScience
Precision BioSciences is a biotechnology company that utilizes a proprietary genome editing method in order to overcome cancers, cure genetic diseases, and enable the development of safer, more productive food sources. The company is headquartered in Durham, North Carolina.Explore more
Precision BioScience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precision BioScience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Precision BioScience launches new products
Check out if Precision BioScience is spiking on competitors!
Website visits: Recent activity has been detected on your website
Precision BioScience, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Precision BioScience has new funding data
Congratulate Masked Content for being promoted to Masked Content at Precision BioScience
Check if Precision BioScience has recently received funding, and reach out quickly before it becomes old news!
Click to see if Precision BioScience had a recent Job posting/layoffs
Earning: See what the market has to say on Precision BioScience recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Precision BioScience as Masked Content
Find more new buyers
Compare Similar Companies to Precision BioScience
Compare insights from companies similar to Precision BioScience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Precision BioScience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Precision BioScience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Precision BioScience.
Precision BioScience financials insights
Gather financial insights about Precision BioScience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$25.6M
2018
Series B
$110M
2019
Debt
$40M
Stock Offering
$145.4M
Precision BioScience Tech Stack
A closer look at the technologies used by Precision BioScience
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
reported S antigen reduction results from the ELIMINATE-B study, with the first patient in cohort 1 showing 50% to 60% sustained S antigen reduction at the lowest dose level.
Medical Research, Pharmaceuticals, Clinical Operations
Project
Precision BioScience has announced PBGENE-HBV, designed for chronic hepatitis B. This is the first and only gene editing approach currently being tested in the clinic for chronic hepatitis B.
Medical Research, Pharmaceuticals, Clinical Operations
Partnership
Partnership, Bioengineering, Medical Research
Precision BioScience News & Media
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B Transcript
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B November 11, 2025 8:00 AM...Precision BioSciences, Inc. (DTIL) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript
Precision BioSciences’ ARCUS platform aims revolutionize genes for HBV and DMD.Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced updated additional preclinical data further validating the scientific rationale supporting the rapid development of PBGENE-DMD, the Company’s first-in-class in vivo gene editing approach for Duchenne muscular dystrophy (DMD), towards first-in-huPrecision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation for PBGENE-DMD for the treatment of Duchenne muscular dystrophy (DMD). “The receipt of Rare Pediatric Disease Designation highlights the significant
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Precision BioScience
Sign Up For FreeTo access detailed company insights
Precision BioSciences is a biotechnology company that utilizes a proprietary genome editing method in order to overcome cancers, cure genetic diseases, and enable the development of safer, more productive food sources. The company is headquartered in Durham, North Carolina.... Read More
